CIBERSAM: Ten years of collaborative translational research in mental disorders;Diez años de investigación traslacional colaborativa en enfermedades mentales: el CIBERSAM

Revista de Psiquiatria y Salud Mental

Volumn 12, Issue 1, 2019, Pages 1-8

  Salagre, Estela ^a,b   Arango, Celso ^a,c   Artigas, Francesc ^a,d   Ayuso Mateos, José Luis ^a,e   Bernardo, Miquel ^a,b   Castro Fornieles, Josefina ^a,f   Bobes, Julio ^a,g   Desco, Manuel ^a,h   Fañanás, Lourdes ^a,b   González Pinto, Ana ^a,i   Haro, Josep María ^a,b   Leza, Juan Carlos ^a,c   Mckenna, Peter J ^a,j   Meana, José Javier ^a,k   Menchón, José Manuel ^a,l   Micó, Juan Antonio ^a,m   Palomo, Tomás ^a,n   Pazos, Ángel ^a,o   Pérez, Víctor ^a,p   Saiz Ruiz, Jerónimo ^a,q   Sanjuán, Julio ^a,r   Tabarés Seisdedos, Rafael ^a,r   Crespo Facorro, Benedicto ^a,s   Casas, Miquel ^a,t   Vilella, Elisabet ^a,u   Palao, Diego ^a,l   Olivares, Jose Manuel ^a,v   Rodriguez Jimenez, Roberto ^a,c   Vieta, Eduard ^a,b   more..

^a CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE SALUD MENTAL CIBERSAM   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^d INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^e UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^f HOSPITAL CLÍNIC   (Spain)

^g UNIVERSITY OF OVIEDO   (Spain)

^h UNIVERSIDAD CARLOS III DE MADRID   (Spain)

ⁱ HOSPITAL TXAGORRITXU   (Spain)

^j FIDMAG GERMANES HOSPITALÀRIES RESEARCH FOUNDATION   (Spain)

^k UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^l HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^m HOSPITAL UNIVERSITARIO PUERTA DEL MAR   (Spain)

ⁿ HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^o UNIVERSITY OF CANTABRIA   (Spain)

^p UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^q HOSPITAL RAMÓN Y CAJAL   (Spain)

^r UNIVERSITY OF VALENCIA   (Spain)

^s UNIVERSITY OF CANTABRIA   (Spain)

^t HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^u IISPV   (Spain)

^v UNIVERSITY HOSPITAL COMPLEX OF VIGO   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; INTERDISCIPLINARY RESEARCH; MENTAL DISEASE; TRANSLATIONAL RESEARCH; HUMAN; INTERNATIONAL COOPERATION; ORGANIZATION AND MANAGEMENT; PUBLICATION;

HUMANS; INTERNATIONAL COOPERATION; MENTAL DISORDERS; PERIODICALS AS TOPIC; TRANSLATIONAL MEDICAL RESEARCH;

EID: 85056243855     PISSN: 18889891     EISSN: 19894600     Source Type: Journal    
DOI: 10.1016/j.rpsm.2018.10.001     Document Type: Article

References (59)

1. Arango, C., Lobo, A., Leading-edge, translational research in psychiatry and related neurosciences in Spain: The CIBERSAM multidisciplinary consortium. Eur J Psychiatry 23:Suppl (2009), 5–6.
2. Rapado-Castro, M., Pazos, A., Fananas, L., Bernardo, M., Ayuso-Mateos, J.L., Leza, J.C., et al. Building up careers in translational neuroscience and mental health research: Education and training in the Centre for Biomedical Research in Mental Health. Rev Psiquiatr Salud Ment 8 (2015), 65–74.
3. Perez-Caballero, L., Perez-Egea, R., Romero-Grimaldi, C., Puigdemont, D., Molet, J., Caso, J.R., et al. Early responses to deep brain stimulation in depression are modulated by anti-inflammatory drugs. Mol Psychiatry 19 (2014), 607–614.
4. Ivorra, J.L., Rivero, O., Costas, J., Iniesta, R., Arrojo, M., Ramos-Rios, R., et al. Replication of previous genome-wide association studies of psychiatric diseases in a large schizophrenia case-control sample from Spain. Schizophr Res 159 (2014), 107–113.
5. Uriguen, L., Gil-Pisa, I., Munarriz-Cuezva, E., Berrocoso, E., Pascau, J., Soto-Montenegro, M.L., et al. Behavioral, neurochemical and morphological changes induced by the overexpression of munc18-1a in brain of mice: relevance to schizophrenia. Transl Psychiatry, 3, 2013, e221.
6. Soria, V., Martinez-Amoros, E., Escaramis, G., Valero, J., Perez-Egea, R., Garcia, C., et al. Differential association of circadian genes with mood disorders: CRY1 and NPAS2 are associated with unipolar major depression and CLOCK and VIP with bipolar disorder. Neuropsychopharmacology 35 (2010), 1279–1289.
7. Cordova-Palomera, A., Fatjo-Vilas, M., Gasto, C., Navarro, V., Krebs, M.O., Fananas, L., Genome-wide methylation study on depression: Differential methylation and variable methylation in monozygotic twins. Transl Psychiatry, 5, 2015, e557.
8. Saiz, P.A., Martinez-Barrondo, S., Garcia-Portilla, M.P., Corcoran, P., Morales, B., Bascaran, M.T., et al. Role of serotonergic polymorphisms in the clinical severity of the panic disorder. Rev Psiquiatr Salud Ment 2 (2009), 35–41.
9. Vidal, R., Garro-Martinez, E., Diaz, A., Castro, E., Florensa-Zanuy, E., Taketo, M.M., et al. Targeting beta-Catenin in GLAST-Expressing Cells: Impact on anxiety and depression-related behavior and hippocampal proliferation. Mol Neurobiol, 2018.
10. Ramos-Quiroga, J.A., Sanchez-Mora, C., Casas, M., Garcia-Martinez, I., Bosch, R., Nogueira, M., et al. Genome-wide copy number variation analysis in adult attention-deficit and hyperactivity disorder. J Psychiatr Res 49 (2014), 60–67.
11. Rodriguez-Jimenez, R., Dompablo, M., Bagney, A., Santabarbara, J., Aparicio, A.I., Torio, I., et al. The MCCB impairment profile in a Spanish sample of patients with schizophrenia: Effects of diagnosis, age, and gender on cognitive functioning. Schizophr Res 169:1-3 (2015), 116–120.
12. Grande, I., Sanchez-Moreno, J., Sole, B., Jimenez, E., Torrent, C., Bonnin, C.M., et al. High cognitive reserve in bipolar disorders as a moderator of neurocognitive impairment. J Affect Disord 208 (2017), 621–627.
13. Rodriguez-Cano, E., Alonso-Lana, S., Sarro, S., Fernandez-Corcuera, P., Goikolea, J.M., Vieta, E., et al. Differential failure to deactivate the default mode network in unipolar and bipolar depression. Bipolar Disord 19 (2017), 386–395.
14. Pina-Camacho, L., del Rey-Mejias, A., Janssen, J., Bioque, M., Gonzalez-Pinto, A., Arango, C., et al. Age at first episode modulates diagnosis-related structural brain abnormalities in psychosis. Schizophr Bull 42 (2016), 344–357.
15. Bernardo, M., Bioque, M., Parellada, M., Saiz Ruiz, J., Cuesta, M.J., Llerena, A., et al. Assessing clinical and functional outcomes in a gene-environment interaction study in first episode of psychosis (PEPs). Rev Psiquiatr Salud Ment 6 (2013), 4–16.
16. Bernardo, M., Bioque, M., What have we learned from research into first-episode psychosis?. Rev Psiquiatr Salud Ment 7 (2014), 61–63.
17. Martinez-Cengotitabengoa, M., MacDowell, K.S., Alberich, S., Diaz, F.J., Garcia-Bueno, B., Rodriguez-Jimenez, R., et al. BDNF and NGF signalling in early phases of psychosis: Relationship with inflammation and response to antipsychotics after 1 year. Schizophr Bull 42 (2016), 142–151.
18. Gasso, P., Mas, S., Bioque, M., Cabrera, B., Lobo, A., Gonzalez-Pinto, A., et al. Impact of NTRK2, DRD2 and ACE polymorphisms on prolactin levels in antipsychotic-treated patients with first-episode psychosis. J Psychopharmacol 32 (2018), 702–710.
19. Garcia-Bueno, B., Bioque, M., Mac-Dowell, K.S., Barcones, M.F., Martinez-Cengotitabengoa, M., Pina-Camacho, L., et al. Pro-/anti-inflammatory dysregulation in patients with first episode of psychosis: Toward an integrative inflammatory hypothesis of schizophrenia. Schizophr Bulletin 40 (2014), 376–387.
20. Parellada, M., Castro-Fornieles, J., Gonzalez-Pinto, A., Pina-Camacho, L., Moreno, D., Rapado-Castro, M., et al. Predictors of functional and clinical outcome in early-onset first-episode psychosis: The child and adolescent first episode of psychosis (CAFEPS) study. J Clin Psychiatry 76 (2015), e1441–e1448.
21. Sugranyes, G., de la Serna, E., Borras, R., Sanchez-Gistau, V., Pariente, J.C., Romero, S., et al. Clinical, cognitive, and neuroimaging evidence of a neurodevelopmental continuum in offspring of probands with schizophrenia and bipolar disorder. Schizophr Bull 43 (2017), 1208–1219.
22. Torrent, C., Bonnin Cdel, M., Martinez-Aran, A., Valle, J., Amann, B.L., Gonzalez-Pinto, A., et al. Efficacy of functional remediation in bipolar disorder: a multicenter randomized controlled study. Am J Psychiatry 170 (2013), 852–859.
23. Fraguas, D., del Rey-Mejias, A., Moreno, C., Castro-Fornieles, J., Graell, M., Otero, S., et al. Duration of untreated psychosis predicts functional and clinical outcome in children and adolescents with first-episode psychosis: A 2-year longitudinal study. Schizophr Res 152 (2014), 130–138.
24. Sanchez-Moreno, J., Bonnin, C.M., Gonzalez-Pinto, A., Amann, B.L., Sole, B., Balanza-Martinez, V., et al. Factors associated with poor functional outcome in bipolar disorder: Sociodemographic, clinical, and neurocognitive variables. Acta Psychiatr Scand, 2018.
25. Salvador, R., Radua, J., Canales-Rodriguez, E.J., Solanes, A., Sarro, S., Goikolea, J.M., et al. Evaluation of machine learning algorithms and structural features for optimal MRI-based diagnostic prediction in psychosis. PloS One, 12, 2017, e0175683.
26. Labad, J., Martorell, L., Huerta-Ramos, E., Cobo, J., Vilella, E., Rubio-Abadal, E., et al. Pharmacogenetic study of the effects of raloxifene on negative symptoms of posmenopausal women with schizophrenia: A double-blind, randomized, placebo-controlled trial. Eur Neuropsychopharmacol 26 (2016), 1683–1689.
27. Garcia-Bueno, B., Gasso, P., MacDowell, K.S., Callado, L.F., Mas, S., Bernardo, M., et al. Evidence of activation of the Toll-like receptor-4 proinflammatory pathway in patients with schizophrenia. J Psychiatry Neurosci 41 (2016), E46–E55.
28. Arias, B., Fabbri, C., Serretti, A., Drago, A., Mitjans, M., Gasto, C., et al. DISC1-TSNAX and DAOA genes in major depression and citalopram efficacy. J Affect Disord 168 (2014), 91–97.
29. Pinacho, R., Villalmanzo, N., Lalonde, J., Haro, J.M., Meana, J.J., Gill, G., et al. The transcription factor SP4 is reduced in posmortem cerebellum of bipolar disorder subjects: Control by depolarization and lithium. Bipolar Disord 13:5-6 (2011), 474–485.
30. Ibarra-Lecue, I., Mollinedo-Gajate, I., Meana, J.J., Callado, L.F., Diez-Alarcia, R., Uriguen, L., Chronic cannabis promotes pro-hallucinogenic signaling of 5-HT2A receptors through Akt/mTOR pathway. Neuropsychopharmacology, 2018.
31. Arango, C., Diaz-Caneja, C.M., McGorry, P.D., Rapoport, J., Sommer, I.E., Vorstman, J.A., et al. Preventive strategies for mental health. Lancet Psychiatry, 2018.
32. Artigas, F., Bortolozzi, A., Therapeutic potential of conjugated siRNAs for the treatment of major depressive disorder. Neuropsychopharmacology, 42, 2017, 371 Disponible en: https://www.nature.com/articles/npp2016182.pdf.
33. Sanchez-Valle, J., Tejero, H., Ibanez, K., Portero, J.L., Krallinger, M., Al-Shahrour, F., et al. A molecular hypothesis to explain direct and inverse co-morbidities between Alzheimer's Disease. Glioblastoma and Lung Cancer. Sci Rep, 7, 2017, 4474.
34. Tabares-Seisdedos, R., Dumont, N., Baudot, A., Valderas, J.M., Climent, J., Valencia, A., et al. No paradox, no progress: Inverse cancer comorbidity in people with other complex diseases. The Lancet Oncology 12 (2011), 604–608.
35. Arango, C., Bernardo, M., Bonet, P., Cabrera, A., Crespo-Facorro, B., Cuesta, M.J., et al. When the healthcare does not follow the evidence: The case of the lack of early intervention programs for psychosis in Spain. Revista de Psiquiatría y Salud Mental 10 (2017), 78–86.
36. Haro, J.M., Ayuso-Mateos, J.L., Bitter, I., Demotes-Mainard, J., Leboyer, M., Lewis, S.W., et al. ROAMER: Roadmap for mental health research in Europe. Int J Methods Psychiatr Res 23:Suppl 1 (2014), 1–14.
37. Artigas, F., Schenker, E., Celada, P., Spedding, M., Llado-Pelfort, L., Jurado, N., et al. Defining the brain circuits involved in psychiatric disorders: IMI-NEWMEDS. Nat Rev Drug Discov 16 (2017), 1–2.
38. Lee, S.H., Ripke, S., Faraone, S.V., Purcell, S.M., Perlis, R.H., et al. Genetic relationship between 5 psychiatric disorders estimated from genome-wide SNPs. Nat Genet 45 (2013), 984–994.
39. Hou, L., Heilbronner, U., Degenhardt, F., Adli, M., Akiyama, K., Akula, N., et al. Genetic variants associated with response to lithium treatment in bipolar disorder: a genome-wide association study. Lancet 387:10023 (2016), 1085–1093.
40. Bipolar Disorder and Schizophrenia Working Group of the Psychiatric Genomics Consortium. Genomic dissection of bipolar disorder and schizophrenia, including 28 subphenotypes. Cell 2018;173(7):1705-15.e16.
41. Anttila, V., Bulik-Sullivan, B., Finucane, H.K., Walters, R.K., Bras, J., Duncan, L., et al. Analysis of shared heritability in common disorders of the brain. Science, 360, 2018.
42. Boedhoe, P.S.W., Schmaal, L., Abe, Y., Alonso, P., Ameis, S.H., Anticevic, A., et al., Cortical abnormalities associated with pediatric and adult obsessive-compulsive disorder: Findings from the ENIGMA Obsessive-Compulsive Disorder Working Group. Am J Psychiatry 175 (2018), 453–462.
43. van Rooij, D., Anagnostou, E., Arango, C., Auzias, G., Behrmann, M., Busatto, G.F., et al., Cortical and subcortical brain morphometry differences between patients with autism spectrum disorder and healthy individuals across the lifespan: Results from the ENIGMA ASD Working Group. Am J Psychiatry 175 (2018), 359–369.
44. Hibar, D.P., Westlye, L.T., Doan, N.T., Jahanshad, N., Cheung, J.W., Ching, C.R.K., et al., Cortical abnormalities in bipolar disorder: An MRI analysis of 6503 individuals from the ENIGMA Bipolar Disorder Working Group. Mol Psychiatry 23 (2018), 932–942.
45. Kelly, S., Jahanshad, N., Zalesky, A., Kochunov, P., Agartz, I., Alloza, C., et al., Widespread white matter microstructural differences in schizophrenia across 4322 individuals: Results from the ENIGMA Schizophrenia DTI Working Group. Mol Psychiatry 23 (2018), 1261–1269.
46. Hegerl, U., Wittmann, M., Arensman, E., Van Audenhove, C., Bouleau, J.H., Van Der Feltz-Cornelis, C., et al. The”European Alliance Against Depression (EAAD)”: A multifaceted, community-based action programme against depression and suicidality. World J Biol Psychiatry 9 (2008), 51–58.
47. Moreno, C., Nuevo, R., Chatterji, S., Verdes, E., Arango, C., Ayuso-Mateos, J.L., Psychotic symptoms are associated with physical health problems independently of a mental disorder diagnosis: Results from the WHO World Health Survey. World Psychiatry 12 (2013), 251–257.
48. GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;385(9963):117-71.
49. Bobes, J., Saiz Ruiz, J., Manuel Montes, J., Mostaza, J., Rico-Villademoros, F., Vieta, E., Spanish consensus on physical health of patients with bipolar disorder. Rev Psiquiatr Salud Ment 1 (2008), 26–37.
50. Giner, J., Saiz Ruiz, J., Bobes, J., Zamorano, E., Lopez, F., Hernando, T., et al. Spanish consensus on the physical health of patients with depressive disorders. Rev Psiquiatr Salud Ment 7 (2014), 195–207.
51. Bobes-Garcia, J., Saiz-Ruiz, J., Bernardo-Arroyo, M., Caballero-Martinez, F., Gilaberte-Asin, I., Ciudad-Herrera, A., Delphi consensus on the physical health of patients with schizophrenia: Evaluation of the recommendations of the Spanish Societies of Psychiatry and Biological Psychiatry by a panel of experts. Actas Esp Psiquiatr 40 (2012), 114–128.
52. Alda, J.A., Soutullo, C., Ramos-Quiroga, J.A., Quintero, J., Hervás, A., Hernández-Otero, I., et al. Expert recommendation: Contributions to clinical practice of the new prodrug lisdexamfetamine dimesylate (LDX) in the treatment of attention deficit hyperactivity disorder (ADHD). Actas Esp Psiquiatr 42:Suppl (2014), 1–16.
53. Bernardo, M., de Dios, C., Perez, V., Ignacio, E., Serrano, M., Vieta, E., et al. Quality indicators in the treatment of patients with depression, bipolar disorder or schizophrenia. Consensus study. Rev Psiquiatr Salud Ment 11 (2018), 66–75.
54. Garriga, M., Pacchiarotti, I., Kasper, S., Zeller, S.L., Allen, M.H., Vázquez, G., et al. Assessment and management of agitation in psychiatry: Expert consensus. World J Biol Psychiatry 17 (2016), 86–128.
55. Pacchiarotti, I., Bond, D.J., Baldessarini, R.J., Nolen, W.A., Grunze, H., Licht, R.W., et al. The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. Am J Psychiatry 170 (2013), 1249–1262.
56. Grupo de trabajo del CIBERSAM para la elaboración de una guía clínica y terapéutica para primeros episodios psicóticos en la infancia y adolescencia. Guía clínica y terapéutica para primeros episodios psicóticos en la infancia y adolescencia Informe de consenso de Recomendaciones. Centro de Investigación Biomédica en Red - CIBER, 2015. Disponible en: https://www.ciberisciii.es/ficheros/SAM/Gu%C3%ADaPEPinfanciaAdolescencia_v5.0.pdf.
57. Perez, V., Salavert, A., Espadaler, J., Tuson, M., Saiz-Ruiz, J., Saez-Navarro, C., et al. Efficacy of prospective pharmacogenetic testing in the treatment of major depressive disorder: Results of a randomized, double-blind clinical trial. BMC Psychiatry, 17, 2017, 250.
58. Hidalgo-Mazzei, D., Mateu, A., Reinares, M., Murru, A., Del Mar Bonnin, C., Varo, C., et al. Psychoeducation in bipolar disorder with a SIMPLe smartphone application: Feasibility, acceptability and satisfaction. J Affect Disord 200 (2016), 58–66.
59. Cebria, A.I., Parra, I., Pamias, M., Escayola, A., Garcia-Pares, G., Punti, J., et al. Effectiveness of a telephone management programme for patients discharged from an emergency department after a suicide attempt: Controlled study in a Spanish population. J Affect Disord 147:1-3 (2013), 269–276.